SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-263935
Filing Date
2020-10-05
Accepted
2020-10-05 16:32:49
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d56461ds3.htm S-3 290057
2 EX-4.1 d56461dex41.htm EX-4.1 351782
3 EX-4.2 d56461dex42.htm EX-4.2 353204
4 EX-4.3 d56461dex43.htm EX-4.3 39725
5 EX-4.4 d56461dex44.htm EX-4.4 37434
6 EX-5.1 d56461dex51.htm EX-5.1 28269
7 EX-23.1 d56461dex231.htm EX-23.1 1520
8 GRAPHIC g56461g99a10.jpg GRAPHIC 39864
  Complete submission text file 0001193125-20-263935.txt   1150655
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249316 | Film No.: 201223976
SIC: 2834 Pharmaceutical Preparations